Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Chronic Renal Failure

Free Subscription Articles published in N Engl J Med Retrieve available abstracts of 36 articles: HTML format

Single Articles

April 2024
1. VAZQUEZ MA, Oliver G, Amarasingham R, Sundaram V, et al
   Pragmatic Trial of Hospitalization Rate in Chronic Kidney Disease.
   N Engl J Med. 2024;390:1196-1206.
   PubMed     Abstract available
   
   
   March 2024
2. XU BP, Wang XT
   Green Dialysis Effluent and Plasma.
   N Engl J Med. 2024;390:e27.
   PubMed    
   
   
   January 2024
3. CHANG LL, Rhee CM, Kalantar-Zadeh K, Woodrow G, et al
   Dietary Protein Restriction in Patients with Chronic Kidney Disease.
   N Engl J Med. 2024;390:86-89.
   PubMed    
   
   
   November 2023
4. BLANKESTIJN PJ, Bots ML
   Effect of Hemodiafiltration or Hemodialysis on Mortality in Kidney Failure. Reply.
   N Engl J Med. 2023;389:e42.
   PubMed    
   
   
   
5. PICCOLI GB, Torreggiani M, Fessi H
   Effect of Hemodiafiltration or Hemodialysis on Mortality in Kidney Failure.
   N Engl J Med. 2023;389:e42.
   PubMed    
   
   
   
6. LABRIOLA L, Fernandes G, Jadoul M
   Effect of Hemodiafiltration or Hemodialysis on Mortality in Kidney Failure.
   N Engl J Med. 2023;389:e42.
   PubMed    
   
   
   
7. ARGILES A, Ficheux A, Duranton F
   Effect of Hemodiafiltration or Hemodialysis on Mortality in Kidney Failure.
   N Engl J Med. 2023;389:e42.
   PubMed    
   
   
   August 2023
8. GOLPER TA
   Improving Dialysis Techniques for Patients?
   N Engl J Med. 2023;389:762-763.
   PubMed    
   
   
   June 2023
9. EGBUNA O, Chertow GM
   Inaxaplin for Proteinuric Kidney Disease in Persons with Two APOL1 Variants. Reply.
   N Engl J Med. 2023;388:2491.
   PubMed    
   
   
   
10. SOLER MJ, Glassock RJ, Fervenza FC
    Inaxaplin for Proteinuric Kidney Disease in Persons with Two APOL1 Variants.
    N Engl J Med. 2023;388:2490.
    PubMed    
    
    
    
11. BLANKESTIJN PJ, Vernooij RWM, Hockham C, Strippoli GFM, et al
    Effect of Hemodiafiltration or Hemodialysis on Mortality in Kidney Failure.
    N Engl J Med. 2023 Jun 16. doi: 10.1056/NEJMoa2304820.
    PubMed     Abstract available
    
    
    
12. HERRINGTON WG, Baigent C, Haynes R
    Empagliflozin in Patients with Chronic Kidney Disease. Reply.
    N Engl J Med. 2023;388:2301-2302.
    PubMed    
    
    
    
13. SINGH AK, Farag YMK, Agarwal R
    Empagliflozin in Patients with Chronic Kidney Disease.
    N Engl J Med. 2023;388:2301.
    PubMed    
    
    
    
14. FUESSL L, Wehrmann F, Schonermarck U
    Empagliflozin in Patients with Chronic Kidney Disease.
    N Engl J Med. 2023;388:2300-2301.
    PubMed    
    
    
    
15. NEUEN BL, Fletcher RA, Heerspink HJL
    Empagliflozin in Patients with Chronic Kidney Disease.
    N Engl J Med. 2023;388:2300.
    PubMed    
    
    
    February 2023
16. HUTH L, Schafer L, Almanzar G, Lupoli G, et al
    Immunologic Effect of Bivalent mRNA Booster in Patients Undergoing Hemodialysis.
    N Engl J Med. 2023 Feb 15. doi: 10.1056/NEJMc2216309.
    PubMed    
    
    
    January 2023
17. AUGUST P
    Chronic Kidney Disease - Another Step Forward.
    N Engl J Med. 2023;388:179-180.
    PubMed    
    
    
    December 2022
18. MC CAUSLAND FR, Singh AK, Claggett BL, Carroll K, et al
    Daprodustat and On-Treatment Cardiovascular Events in Chronic Kidney Disease. Reply.
    N Engl J Med. 2022;387:2482-2485.
    PubMed    
    
    
    
19. HUANG C, He Y, Li Y
    Daprodustat and On-Treatment Cardiovascular Events in Chronic Kidney Disease.
    N Engl J Med. 2022;387:2482.
    PubMed    
    
    
    
20. ROJAS-RIVERA J, Carriazo S, Ortiz A
    Daprodustat and On-Treatment Cardiovascular Events in Chronic Kidney Disease.
    N Engl J Med. 2022;387:2481-2482.
    PubMed    
    
    
    November 2022
21. HERRINGTON WG, Staplin N, Wanner C, Green JB, et al
    Empagliflozin in Patients with Chronic Kidney Disease.
    N Engl J Med. 2022 Nov 4. doi: 10.1056/NEJMoa2204233.
    PubMed     Abstract available
    
    
    
22. BHANDARI S, Mehta S, Khwaja A, Cleland JGF, et al
    Renin-Angiotensin System Inhibition in Advanced Chronic Kidney Disease.
    N Engl J Med. 2022 Nov 3. doi: 10.1056/NEJMoa2210639.
    PubMed     Abstract available
    
    
    October 2022
23. TUTTLE KR, Jones CR, Daratha KB, Koyama AK, et al
    Incidence of Chronic Kidney Disease among Adults with Diabetes, 2015-2020.
    N Engl J Med. 2022;387:1430-1431.
    PubMed    
    
    
    June 2022
24. LEVEY AS, Grams ME, Inker LA
    Uses of GFR and Albuminuria Level in Acute and Chronic Kidney Disease.
    N Engl J Med. 2022;386:2120-2128.
    PubMed    
    
    
    March 2022
25. MORELLE J, Davies S, Devuyst O
    AQP1 Promoter Variant, Water Transport, and Outcome in Peritoneal Dialysis. Reply.
    N Engl J Med. 2022;386:1098.
    PubMed    
    
    
    
26. MORITA H, Komuro I
    AQP1 Promoter Variant, Water Transport, and Outcome in Peritoneal Dialysis.
    N Engl J Med. 2022;386:1096-1098.
    PubMed    
    
    
    
27. ZHOU XJ, Xu X, Dong J
    AQP1 Promoter Variant, Water Transport, and Outcome in Peritoneal Dialysis.
    N Engl J Med. 2022;386:1096.
    PubMed    
    
    
    
28. XIE X, Zhang X
    Primary Hyperoxaluria.
    N Engl J Med. 2022;386:976.
    PubMed    
    
    
    December 2021
29. WHEELER DC
    Chlorthalidone in Advanced Chronic Kidney Disease - Have We Missed a Trick?
    N Engl J Med. 2021;385:2574-2575.
    PubMed    
    
    
    November 2021
30. SINGH AK, Carroll K, McMurray JJV, Solomon S, et al
    Daprodustat for the Treatment of Anemia in Patients Not Undergoing Dialysis.
    N Engl J Med. 2021 Nov 5. doi: 10.1056/NEJMoa2113380.
    PubMed     Abstract available
    
    
    
31. SINGH AK, Carroll K, Perkovic V, Solomon S, et al
    Daprodustat for the Treatment of Anemia in Patients Undergoing Dialysis.
    N Engl J Med. 2021 Nov 5. doi: 10.1056/NEJMoa2113379.
    PubMed     Abstract available
    
    
    
32. AGARWAL R, Sinha AD, Cramer AE, Balmes-Fenwick M, et al
    Chlorthalidone for Hypertension in Advanced Chronic Kidney Disease.
    N Engl J Med. 2021 Nov 5. doi: 10.1056/NEJMoa2110730.
    PubMed     Abstract available
    
    
    
33. TEITELBAUM I
    Peritoneal Dialysis.
    N Engl J Med. 2021;385:1786-1795.
    PubMed    
    
    
    October 2021
34. MORELLE J, Marechal C, Yu Z, Debaix H, et al
    AQP1 Promoter Variant, Water Transport, and Outcomes in Peritoneal Dialysis.
    N Engl J Med. 2021;385:1570-1580.
    PubMed     Abstract available
    
    
    
35. CHERTOW GM, Eckardt KU
    Vadadustat for Anemia in Patients with Dialysis-Dependent or Non-Dialysis-Dependent Chronic Kidney Disease. Reply.
    N Engl J Med. 2021;385:e56.
    PubMed    
    
    
    
36. BUNN HF
    Vadadustat for Anemia in Patients with Dialysis-Dependent or Non-Dialysis-Dependent Chronic Kidney Disease.
    N Engl J Med. 2021;385:e56.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Chronic Renal Failure is free of charge.